Intrinsic calcium dynamics control botulinum toxin A susceptibility in distinct neuronal populations

Cell Calcium

Volumn 47, Issue 5, 2010, Pages 419-424

  Grumelli, Carlotta ^a   Corradini, Irene ^a   Matteoli, Michela ^a,b   Verderio, Claudia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Botulinum A; Calcium transients; Exocytosis; GABAergic neurons; Glutamatergic neurons; SNAP 25

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BOTULINUM TOXIN A; CALCIUM; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; POTASSIUM CHLORIDE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL POPULATION; CONTROLLED STUDY; EXOCYTOSIS; FETUS; GENE SILENCING; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPSE;

EID: 77952953687     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2010.03.002     Document Type: Article

References (29)

1. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell. 2006, 7:631-643.
2. Südhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477.
3. 2+ channel is functionally coupled to the exocytotic machinery. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:248-253.
4. 2+ channels by SNAP-25, syntaxin and synaptotagmin. Nat. Neurosci. 1999, 2:939-941.
5. Verderio C, Pozzi D., Pravettoni E., et al. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 2004, 41:599-610.
6. Pozzi D., Condliffe S., Bozzi Y., et al. Activity-dependent phosphorylation of Ser187 is required for SNAP-25-negative modulation of neuronal voltage-gated calcium channels. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:323-328.
7. Hayashi T., McMahon H., Yamasaki S., et al. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J. 1994, 13:5051-5061.
8. Meng J., Ovsepian S.V., Wan J., et al. Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J. Neurosci. 2009, 29:4981-4992.
9. Bigalke H, Heller I., Bizzini B., Habermann E. Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn. Schmiedebergs Arch. Pharmacol. 1981, 316:244-251.
10. Ashton A., Dolly J.O. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J. Neurochem. 1988, 50:1808-1816.
11. Verderio C., Grumelli C., Raiteri L., Coco S., et al. Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 2007, 8:142-153.
12. Delgado-Martínez I., Nehring R.B., Sørensen J.B. Differential abilities of SNAP-25 homologs to support neuronal function. J. Neurosci. 2007, 27:9380-9391.
13. Bronk P., Deák F., Wilson M.C., Liu X., Südhof T.C., Kavalali E.T. Differential effects of SNAP-25 deletion on Ca2+-dependent and Ca2+-independent neurotransmission. J. Neurophysiol. 2007, 98:794-806.
14. Tafoya L.C., Mameli M., Miyashita T., Guzowski J.F., Valenzuela C.F., Wilson M.C. Expression and function of SNAP-25 as a universal SNARE component in GABAergic neurons. J. Neurosci. 2006, 26:7826-7838.
15. Bragina L., Candiracci C., Barbaresi P., Giovedì S., Benfenati F., Conti F. Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex. Neuroscience 2007, 146:1829-1840.
16. Garbelli R., Inverardi F., Medici V., et al. Heterogeneous expression of SNAP-25 in rat and human brain. J. Comp. Neurol. 2008, 506:373-386.
17. Mandolesi G., Vanni V., Cesa R., et al. Distribution of the SNAP25 and SNAP23 synaptosomal-associated protein isoforms in rat cerebellar cortex. Neuroscience 2009, 164:1084-1096.
18. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80:717-766.
19. Costantin L., Bozzi Y., Richichi C., et al. Antiepileptic effects of botulinum neurotoxin E. J. Neurosci. 2005, 25:1943-1951.
20. Verderio C., Rossetto O., Grumelli C., Frassoni C., Montecucco C., Matteoli M. Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Rep. 2006, 7:995-999.
21. Martens H., Weston M.C., Boulland J.L., et al. Unique luminal localization of VGAT-C terminus allows for selective labeling of active cortical GABAergic synapses. J. Neurosci. 2008, 28:13125-13131.
22. Bajohrs M., Rickman C., Binz T., Davletov B. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. EMBO Rep. 2004, 5:1090-1095.
23. Banerjee A., Kowalchyk J.A., DasGupta B.R., Martin T.F. SNAP-25 is required for a late postdocking step in Ca2+ dependent exocytosis. J. Biol. Chem. 1996, 271:20227-20230.
24. Gerona R.R., Larsen E.C., Kowalchyk J.A., Martin T.F. The C terminus of SNAP25 is essential for Ca(2+)-dependent binding of synaptotagmin to SNARE complexes. J. Biol. Chem. 2000, 275:6328-6336.
25. Capogna M., McKinney R.A., O'Connor V., Gähwiler B.H., Thompson S.M. Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J. Neurosci. 1997, 17:7190-7202.
26. Trudeau L.E., Fang Y., Haydon P.G. Modulation of an early step in the secretory machinery in hippocampal nerve terminals. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7163-7168.
27. Sakaba T., Stein A., Jahn R., Neher E. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage. Science 2005, 309:491-494.
28. Grumelli C., Berghuis P., Pozzi D., Caleo, et al. Calpain activity contributes to the control of SNAP-25 levels in neurons. Mol. Cell Neurosci. 2008, 39:314-332.
29. Kitamura Y., Matsuka Y., Spigelman I., et al. Botulinum toxin type a (150kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Neuroscience 2009, 159:1422-1429.